BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12498984)

  • 1. A low molecular weight antioxidant decreases weight and lowers tumor incidence.
    Mitchell JB; Xavier S; DeLuca AM; Sowers AL; Cook JA; Krishna MC; Hahn SM; Russo A
    Free Radic Biol Med; 2003 Jan; 34(1):93-102. PubMed ID: 12498984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the hydroxylamine Tempol-H as an in vivo radioprotector.
    Hahn SM; Krishna MC; DeLuca AM; Coffin D; Mitchell JB
    Free Radic Biol Med; 2000 Mar; 28(6):953-8. PubMed ID: 10802227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential use of nitroxides in radiation oncology.
    Hahn SM; Krishna CM; Samuni A; DeGraff W; Cuscela DO; Johnstone P; Mitchell JB
    Cancer Res; 1994 Apr; 54(7 Suppl):2006s-2010s. PubMed ID: 8137329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The nitroxide tempol has similar antioxidant effects as physiological levels of 17beta-oestradiol in reversing ovariectomy-induced oxidative stress in mice liver and kidney.
    Enli Y; Oztekin O; Pinarbasili RD
    Scand J Clin Lab Invest; 2009; 69(4):526-34. PubMed ID: 19343575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer chemoprevention by the antioxidant tempol in Atm-deficient mice.
    Schubert R; Erker L; Barlow C; Yakushiji H; Larson D; Russo A; Mitchell JB; Wynshaw-Boris A
    Hum Mol Genet; 2004 Aug; 13(16):1793-802. PubMed ID: 15213104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive effect of mitochondria-targeted proxyl nitroxides.
    Dikalova AE; Kirilyuk IA; Dikalov SI
    Redox Biol; 2015; 4():355-62. PubMed ID: 25677087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tempol attenuates cocaine-induced death of PC12 cells through decreased oxidative damage.
    Numa R; Baron M; Kohen R; Yaka R
    Eur J Pharmacol; 2011 Jan; 650(1):157-62. PubMed ID: 20969850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of tempol radioprotection in a murine tumor model.
    Hahn SM; Sullivan FJ; DeLuca AM; Krishna CM; Wersto N; Venzon D; Russo A; Mitchell JB
    Free Radic Biol Med; 1997; 22(7):1211-6. PubMed ID: 9098095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and metabolic effects of tempol in obese ZSF1 rats--distinct role for superoxide and hydrogen peroxide in diabetic renal injury.
    Rafikova O; Salah EM; Tofovic SP
    Metabolism; 2008 Oct; 57(10):1434-44. PubMed ID: 18803950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats.
    Nassar T; Kadery B; Lotan C; Da'as N; Kleinman Y; Haj-Yehia A
    Eur J Pharmacol; 2002 Feb; 436(1-2):111-8. PubMed ID: 11834254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive response to prolonged tempol in the spontaneously hypertensive rat.
    Welch WJ; Mendonca M; Blau J; Karber A; Dennehy K; Patel K; Lao YS; José PA; Wilcox CS
    Kidney Int; 2005 Jul; 68(1):179-87. PubMed ID: 15954907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidative Effects of Tempol on Mitochondrial Dysfunction in Diabetic Nephropathy.
    Ranjbar A; Kheiripour N; Ghasemi H; Seif Rabiei MA; Dadras F; Khoshjou F
    Iran J Kidney Dis; 2018 Mar; 12(2):84-90. PubMed ID: 29507270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors influencing nitroxide reduction and cytotoxicity in vitro.
    Samuni Y; Gamson J; Samuni A; Yamada K; Russo A; Krishna MC; Mitchell JB
    Antioxid Redox Signal; 2004 Jun; 6(3):587-95. PubMed ID: 15130285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tempol inhibits neutrophil and hydrogen peroxide-mediated DNA damage.
    Hahn SM; Mitchell JB; Shacter E
    Free Radic Biol Med; 1997; 23(6):879-84. PubMed ID: 9378367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice.
    Zhang QS; Eaton L; Snyder ER; Houghtaling S; Mitchell JB; Finegold M; Van Waes C; Grompe M
    Cancer Res; 2008 Mar; 68(5):1601-8. PubMed ID: 18316625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimutagenicity of a low molecular weight superoxide dismutase mimic against oxidative mutagens.
    DeGraff WG; Krishna MC; Russo A; Mitchell JB
    Environ Mol Mutagen; 1992; 19(1):21-6. PubMed ID: 1310080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of tempol and redox-cycling nitroxides in models of oxidative stress.
    Wilcox CS
    Pharmacol Ther; 2010 May; 126(2):119-45. PubMed ID: 20153367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen sulphide and tempol treatments improve the blood pressure and renal excretory responses in spontaneously hypertensive rats.
    Ahmad FU; Sattar MA; Rathore HA; Tan YC; Akhtar S; Jin OH; Pei YP; Abdullah NA; Johns EJ
    Ren Fail; 2014 May; 36(4):598-605. PubMed ID: 24502512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polynitroxyl-albumin (PNA) plus tempol attenuate lung capillary leak elicited by prolonged intestinal ischemia and reperfusion(1).
    Zhang S; Li H; Ma L; Trimble CE; Kuppusamy P; Hsia CJ; Carden DL
    Free Radic Biol Med; 2000 Jul; 29(1):42-50. PubMed ID: 10962204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats.
    Moreno JM; Rodríguez Gómez I; Wangensteen R; Osuna A; Bueno P; Vargas F
    Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E776-83. PubMed ID: 15941780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.